# GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer

> **NCT06111105** · — · RECRUITING · sponsor: **Claus Lindbjerg Andersen** · enrollment: 590 (estimated)

## Conditions studied

- Colorectal Cancer Stage III
- Liver Metastasis Colon Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06111105
- **Lead sponsor:** Claus Lindbjerg Andersen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2031-07-31
- **Target enrollment:** 590 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111105, "GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06111105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*